Pfizer Financial Analysis
Q4, 2009
| Mar 2010 |
£135 |
Astellas: Pipeline, Products, Performance, Potential
| Jan 2010 |
£595 |
Eli Lilly Pipeline Products Performance Potential
| Jan 2010 |
£595 |
Pharmaceutical Associates, Inc.-Company Report
| Jan 2010 |
£505 |
Pharma Stulln GmbH-Company Report
| Jan 2010 |
£505 |
Pharmagenesis Inc-Company Report
| Jan 2010 |
£505 |
Pharis Biotec GmbH-Company Report
| Jan 2010 |
£505 |
PharmaEngine, Inc.-Company Report
| Jan 2010 |
£505 |
Pfizer Limited-Company Report
| Jan 2010 |
£505 |
PepTx, Inc.-Company Report
| Jan 2010 |
£505 |
Pevion Biotech Ltd.-Company Report
| Jan 2010 |
£505 |
PharmaIN Corporation-Company Report
| Jan 2010 |
£505 |
PH&T S.p.A.-Company Report
| Jan 2010 |
£505 |
Phafag AG-Company Report
| Jan 2010 |
£505 |
Pharmaniaga Berhad-Company Report
| Jan 2010 |
£505 |
Pharmstandard-Company Report
| Jan 2010 |
£505 |
Phase 2 Discovery, Inc.-Company Report
| Jan 2010 |
£505 |
Pherin Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Philogen S.p.A-Company Report
| Jan 2010 |
£505 |
Pharminox Ltd-Company Report
| Jan 2010 |
£505 |
Pharmbio Korea Co., Ltd-Company Report
| Jan 2010 |
£505 |
PharmaMar-Company Report
| Jan 2010 |
£505 |
Peptimmune, Inc-Company Report
| Jan 2010 |
£505 |
Pharmascience Inc.-Company Report
| Jan 2010 |
£505 |
Pharmathen S.A.-Company Report
| Jan 2010 |
£505 |
Pharmalink AB-Company Report
| Jan 2010 |
£505 |
Pei Li Pharmaceutical Ind. Co., Ltd.-Company Report
| Jan 2010 |
£505 |
Paddock Laboratories, Inc.-Company Report
| Jan 2010 |
£505 |
Pacira Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Paladin Labs Inc.-Company Report
| Jan 2010 |
£505 |
PALAU PHARMA-Company Report
| Jan 2010 |
£505 |
Paloma Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Pacific Pharmaceuticals Limited-Company Report
| Jan 2010 |
£505 |
Pacific Pharmaceutical Co., Ltd.-Company Report
| Jan 2010 |
£505 |
Oxford BioMedica plc-Company Report
| Jan 2010 |
£505 |
Oxagen Limited-Company Report
| Jan 2010 |
£505 |
Ozone Pharmaceuticals Ltd.-Company Report
| Jan 2010 |
£505 |
Pacgen Biopharmaceuticals Corporation-Company Report
| Jan 2010 |
£505 |
Pamlab, L.L.C. (formerly Pan American Laboratories, Inc.)-Company Report
| Jan 2010 |
£505 |
Panacea Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Patrys Limited-Company Report
| Jan 2010 |
£505 |
PDC Biotech GmbH-Company Report
| Jan 2010 |
£505 |
Pedinol Pharmacal Inc.-Company Report
| Jan 2010 |
£505 |
PhiloGene Inc.-Company Report
| Jan 2010 |
£505 |
Pascual Laboratories Inc.-Company Report
| Jan 2010 |
£505 |
Paratek Pharmaceuticals, Inc-Company Report
| Jan 2010 |
£505 |
Panacea Biotec Ltd-Company Report
| Jan 2010 |
£505 |
Pangenetics BV-Company Report
| Jan 2010 |
£505 |
Panjon Pharma Ltd.-Company Report
| Jan 2010 |
£505 |
Pantarhei Bioscience-Company Report
| Jan 2010 |
£505 |
PepTcell Limited-Company Report
| Jan 2010 |
£505 |
Photopharmica Ltd-Company Report
| Jan 2010 |
£505 |
Protein Sciences Corporation-Company Report
| Jan 2010 |
£505 |
ProtAffin Biotechnologie AG-Company Report
| Jan 2010 |
£505 |
Protemix Corporation Limited-Company Report
| Jan 2010 |
£505 |
ProteomTech, Inc.-Company Report
| Jan 2010 |
£505 |
Protez Pharmaceuticals-Company Report
| Jan 2010 |
£505 |
ProStrakan Group plc-Company Report
| Jan 2010 |
£505 |
Proreo Pharma AG-Company Report
| Jan 2010 |
£505 |
Prometheus Laboratories, Inc.-Company Report
| Jan 2010 |
£505 |
ProMetic Life Sciences Inc.-Company Report
| Jan 2010 |
£505 |
Proneuron Biotechnologies, Inc.-Company Report
| Jan 2010 |
£505 |
Proper Nutrition, Inc.-Company Report
| Jan 2010 |
£505 |
Protox Therapeutics Inc.-Company Report
| Jan 2010 |
£505 |
PT Kalbe Farma Tbk.-Company Report
| Jan 2010 |
£505 |
Qilu Pharmaceutical CO., LTD.-Company Report
| Jan 2010 |
£505 |
Q-Med AB-Company Report
| Jan 2010 |
£505 |
Biogen Idec: Pipeline - Products - Performance - Potential
| Jan 2010 |
£595 |
Dainippon Sumitomo: Pipeline, Products, Performance, Potential
| Jan 2010 |
£595 |
Purzer Pharmaceutical Co. Ltd.-Company Report
| Jan 2010 |
£505 |
Purdue Pharma L.P-Company Report
| Jan 2010 |
£505 |
PT Darya-Varia Laboratoria Tbk-Company Report
| Jan 2010 |
£505 |
PT Kimia Farma Tbk-Company Report
| Jan 2010 |
£505 |
PT. Pyridam Farma Tbk-Company Report
| Jan 2010 |
£505 |
PT Bernofarm-Company Report
| Jan 2010 |
£505 |
Prolexys Pharmaceuticals, Inc-Company Report
| Jan 2010 |
£505 |
Procaps SA-Company Report
| Jan 2010 |
£505 |
Plethico Pharmaceuticals Ltd.-Company Report
| Jan 2010 |
£505 |
Plethora Solutions Limited-Company Report
| Jan 2010 |
£505 |
Plexxikon Inc-Company Report
| Jan 2010 |
£505 |
PLx Pharma Inc.-Company Report
| Jan 2010 |
£505 |
Pisa Farmaceutica Mexicana-Company Report
| Jan 2010 |
£505 |
Piramal Healthcare Limited (formerly Nicholas Piramal India Limited)-Company Report
| Jan 2010 |
£505 |
PhotoCure ASA-Company Report
| Jan 2010 |
£505 |
Phynova Group Plc-Company Report
| Jan 2010 |
£505 |
Pieris AG-Company Report
| Jan 2010 |
£505 |
Pinnacle Pharma del Peru S.A.C.-Company Report
| Jan 2010 |
£505 |
Polaris Group-Company Report
| Jan 2010 |
£505 |
Polpharma SA-Company Report
| Jan 2010 |
£505 |
Presidio Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Primus Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Probiomed, S.A. de C.V-Company Report
| Jan 2010 |
£505 |
Probiotec Limited-Company Report
| Jan 2010 |
£505 |
PregLem SA-Company Report
| Jan 2010 |
£505 |
Prasco Laboratories-Company Report
| Jan 2010 |
£505 |
Polymun Scientific Immunbiologische Forschung GmbH-Company Report
| Jan 2010 |
£505 |
Polyphor Ltd-Company Report
| Jan 2010 |
£505 |
Popular Pharmaceuticals Ltd.-Company Report
| Jan 2010 |
£505 |
PR Pharmaceuticals, Inc.-Company Report
| Jan 2010 |
£505 |
Philusa Corporation-Company Report
| Jan 2010 |
£505 |
